Sartorius Stedim Biotech: Proposed Dividend of €0.69
The Board of Directors of Sartorius Stedim Biotech S.A. has approved a proposed dividend of €0.69 per share for the fiscal year 2025, subject to the approval of the Mixed General Meeting of shareholders.
The Board of Directors, meeting on February 4, 2026, proposes a dividend payment of €0.69 per share for the fiscal year 2025. This amount is identical to that paid in 2024. The total amount distributed would amount to €67.1 million. The proposal will be submitted to the Mixed General Meeting of shareholders on March 24, 2026. The dividend will be paid to shareholders starting April 2, 2026.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.